Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy

Jeffrey D. Jensen; Michael Lynch

doi:10.1038/s41437-020-0314-z

Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy

Jeffrey D. Jensen, Michael Lynch

Life Sciences, School of (SOLS)

Research output: Contribution to journal › Comment/debate › peer-review

22 Scopus citations

Original language	English (US)
Pages (from-to)	619-620
Number of pages	2
Journal	Heredity
Volume	124
Issue number	5
DOIs	https://doi.org/10.1038/s41437-020-0314-z
State	Published - May 1 2020

ASJC Scopus subject areas

Genetics
Genetics(clinical)

Access to Document

10.1038/s41437-020-0314-z

Cite this

@article{4a46c3098a574460adf2cac1b65eb925,

title = "Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy",

author = "Jensen, {Jeffrey D.} and Michael Lynch",

year = "2020",

month = may,

day = "1",

doi = "10.1038/s41437-020-0314-z",

language = "English (US)",

volume = "124",

pages = "619--620",

journal = "Heredity",

issn = "0018-067X",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy

AU - Jensen, Jeffrey D.

AU - Lynch, Michael

PY - 2020/5/1

Y1 - 2020/5/1

UR - http://www.scopus.com/inward/record.url?scp=85082956818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85082956818&partnerID=8YFLogxK

U2 - 10.1038/s41437-020-0314-z

DO - 10.1038/s41437-020-0314-z

M3 - Comment/debate

AN - SCOPUS:85082956818

SN - 0018-067X

VL - 124

SP - 619

EP - 620

JO - Heredity

JF - Heredity

IS - 5

ER -

Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this